IBIO · iBio, Inc. · Proposed Sales
$0.73
-0.03 (-4.00%)
At close · Nov 13
Return incl. dividend (before tax)
Q4 2022 earnings call transcript
Going-concern doubt
— cleared Nov 10, 2026
The latest filing states the doubt was alleviated.
“Despite this liquidity position, the history of significant losses, the negative cash flow from operations, and the dependence by us on our ability to obtain additional financing to fund our operations raised substantial doubt in the past about our ability to continue as a going concern. However, based on our current liquidity we concluded the substantial doubt has been alleviated.”View the 10-Q filed Nov 10, 2026
Market Cap
$51.55M
Shares
70.46M
Volume · Nov 13
463.73K
Avg daily vol (3M)
696.5K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
1420720
CUSIP
451033708
13F (30d)
40 filings
33 filers
Visit website
Investor relations